2022 annual financial data
Mineralys Therapeutics 2022 Operating margin
Mineralys Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -31,479,000 USD and net income was -29,799,000 USD.
Operating cash flow was -29,221,000 USD.
Get free Mineralys Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -31,479,000 USD
- Net income
- -29,799,000 USD
- Operating cash flow
- -29,221,000 USD